London-headquartered biotech startup Verdiva has emerged from stealth with a whopping $410mn for a new range of drugs aimed at tackling the obesity epidemic. It’s one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market. Verdiva looks to challenge the dominance of Novo Nordisk and Eli Lilly, the makers of the two most popular weight loss [...]
The resignation landed on a Tuesday, and the manager never saw it coming. A senior engineer with three years at the company had earned strong reviews and showed no obvious signs of frustration. Then came the resignation. A competing offer had already been signed. Looking back, the warning signs were easy to spot. Survey scores […]<br /> This story continues at The Next Web [...]